Opportunities for New Testing to Screen Blood Donations

The blood screen testing market is apparently plateauing, with risks of decline over the next few years, as more patents expire. Additionally, there have been structural industry changes that could accelerate this, particularly the acquisition of Gen-Probe by Hologic. The acquisition also affects Novartis in the nucleic acid testing part of the business. However, there… Read More Opportunities for New Testing to Screen Blood Donations